文献速递心境障碍

抑郁症患者脑内5-羟色胺释放减少:一项[11C]Cimbi-36 PET联合d-苯丙胺激发研究

Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge.
PubMed 文献 · Biol Psychiatry · 2022-10-29

该研究采用[11C]Cimbi-36 PET联合d-苯丙胺激发,比较17例未用药重性抑郁发作患者与20名健康对照的脑内5-HT释放能力。结果发现健康对照组额叶皮层BPND显著下降,而患者组无显著变化,患者组ΔBPND显著低于对照组,提示抑郁症存在5-HT释放功能异常。

要点

  • d-苯丙胺激发后健康对照额叶BPND显著下降,患者组无显著变化。
  • 患者组ΔBPND显著低于健康对照(6.5%±20% vs 15%±14%,p=.041)。
  • 首次直接证据支持抑郁症5-HT神经传递功能异常。

核心结论

  • 抑郁症患者脑内5-HT释放能力降低,支持5-HT神经传递功能障碍参与抑郁症病理生理。

研究设计与样本

  • 17例未用药重性抑郁发作患者(3女/14男,平均年龄44±13岁,HAMD评分21±4)与20名健康对照(3女/17男,平均年龄32±9岁)接受[11C]Cimbi-36 PET扫描。
  • 在口服0.5 mg/kg d-苯丙胺前和3小时后分别进行90分钟动态PET,以额叶皮层为主要感兴趣区,小脑为参考区,用多线性分析-1计算5-HT2A受体不可置换结合。

主要发现

  • 健康对照组额叶BPND在d-苯丙胺后显著降低(1.04±0.31 vs 0.87±0.24,p<.001)。
  • 重性抑郁发作组额叶BPND在d-苯丙胺后无显著变化(0.97±0.25 vs 0.92±0.22,无显著性)。
  • 重性抑郁发作组ΔBPND显著低于健康对照组(6.5%±20% vs 15%±14%,p=.041)。

临床怎么用

  • 该研究为抑郁症5-HT能神经传递障碍提供了直接在体证据,支持5-HT系统作为抑郁症治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The serotonin hypothesis of depression proposes that diminished serotonergic (5-HT) neurotransmission is causal in the pathophysiology of the disorder. Although the hypothesis is over 50 years old, there is no firm in vivo evidence for diminished 5-HT neurotransmission. We recently demonstrated that the 5-HT2A receptor agonist positron emission tomography (PET) radioligand [11C]Cimbi-36 is sensitive to increases in extracellular 5-HT induced by an acute d-amphetamine challenge. Here we applied [11C]Cimbi-36 PET to compare brain 5-HT release capacity in patients experiencing a major depressive episode (MDE) to that of healthy control subjects (HCs) without depression. METHODS: Seventeen antidepressant-free patients with MDE (3 female/14 male, mean age 44 ± 13 years, Hamilton Depression Rating Scale score 21 ± 4 [range 16-30]) and 20 HCs (3 female/17 male, mean age 32 ± 9 years) underwent 90-minute dynamic [11C]Cimbi-36 PET before and 3 hours after a 0.5-mg/kg oral dose of d-amphetamine. Frontal cortex (main region of interest) 5-HT2A receptor nondisplaceable binding was calculated from kinetic analysis using the multilinear analysis-1 approach with the cerebellum as the reference region. RESULTS: Following d-amphetamine administration, frontal nondisplaceable binding potential (BPND) was significantly reduced in the HC group (1.04 ± 0.31 vs. 0.87 ± 0.24, p < .001) but not in the MDE group (0.97 ± 0.25 vs. 0.92 ± 0.22, not significant). ΔBPND of the MDE group was significantly lower than that of the HC group (HC: 15% ± 14% vs. MDE: 6.5% ± 20%, p = .041). CONCLUSIONS: This first direct assessment of 5-HT release capacity in people with depression provides clear evidence for dysfunctional serotonergic neurotransmission in depression by demonstrating reduced 5-HT release capacity in patients experiencing an MDE.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Erritzoe D, Godlewska BR, Rizzo G, et al. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge. Biol Psychiatry. 2022. PMID: 36635177. doi:10.1016/j.biopsych.2022.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。